Endothelial-to-Mesenchymal Transition in Cancer - PubMed (original) (raw)

Review

Endothelial-to-Mesenchymal Transition in Cancer

Nicolas Clere et al. Front Cell Dev Biol. 2020.

Abstract

Cancer is one of the most important causes of morbidity and mortality worldwide. Tumor cells grow in a complex microenvironment constituted of immune, stromal, and vascular cells that supports growth, angiogenesis, and metastasis. Endothelial cells (ECs) are major components of the vascular microenvironment. These cells have been described for their plasticity and potential to transdifferentiate into mesenchymal cells through a process known as endothelial-to-mesenchymal transition (EndMT). This complex process is controlled by various factors, by which ECs convert into a phenotype characterized by mesenchymal protein expression and motile, contractile morphology. Initially described in normal heart development, EndMT is now identified in several pathologies, and especially in cancer. In this review, we highlight the process of EndMT in the context of cancer and we discuss it as an important adaptive process of the tumor microenvironment that favors tumor growth and dissemination but also resistance to treatment. Thus, we underline targeting of EndMT as a potential therapeutic strategy.

Keywords: CAF; cancer; endothelial; mesenchymal; metastasis; plasticity; resistance.

Copyright © 2020 Clere, Renault and Corre.

PubMed Disclaimer

Figures

FIGURE 1

FIGURE 1

Schematic representation of the EndMT process in cancer. TGF-β, transforming growth factor-β; PDGF, platelet derived growth factor; HGF, hepatocyte growth factor; CAFs, cancer-associated fibroblasts; OPN, osteopontin; EVs: extracellular vesicles.

References

    1. Anderberg C., Cunha S. I., Zhai Z., Cortez E., Pardali E., Johnson J. R., et al. (2013). Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination. J. Exp. Med. 210 563–579. 10.1084/jem.20120662 - DOI - PMC - PubMed
    1. Banerjee D., Barton S. M., Grabham P. W., Rumeld A. L., Okochi S., Street C., et al. (2020). High-dose radiation increases notch1 in tumor vasculature. Int. J. Radiat. Oncol. Biol. Phys. 106 857–866. 10.1016/j.ijrobp.2019.11.010 - DOI - PMC - PubMed
    1. Bu L., Baba H., Yoshida N., Miyake K., Yasuda T., Uchihara T., et al. (2019). Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment. Oncogene 38 4887–4901. 10.1038/s41388-019-0765-y - DOI - PubMed
    1. Chen X., Cai J., Zhou X., Chen L., Gong Y., Gao Z., et al. (2015). Protective effect of spironolactone on endothelial-to-mesenchymal transition in HUVECs via notch pathway. Cell Physiol. Biochem. 36 191–200. 10.1159/000374063 - DOI - PubMed
    1. Cho J. G., Lee A., Chang W., Lee M. S., Kim J. (2018). Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction. Front. Immunol. 9:294. 10.3389/fimmu.2018.00294 - DOI - PMC - PubMed

Publication types

LinkOut - more resources